# State Street SPDR S&P Pharmaceuticals ETF (XPH) — Overview

XPH · NYSE · Fund

Canonical page: https://www.lighthorse.io/tickers/xph

## Price

Last close $63.02 on Oct 15, 2026. 52-week range $48.01 – $74.06.

## Fund profile

XPH tracks an equal-weighted index of US pharmaceutical companies.

| Metric | Value |
| --- | --- |
| Issuer | State Street Global Advisors |
| Industry | Healthcare |
| Inception | Jun 19, 2006 |
| Assets under management | $444.2M |
| Expense ratio | 0.35% |
| Net asset value | $63.09 (as of Oct 15, 2026) |
| Distributions | Quarterly |
| Leverage | 1x |

## Frequently Asked Questions

### What is State Street SPDR S&P Pharmaceuticals ETF (XPH)?

XPH tracks an equal-weighted index of US pharmaceutical companies.

### What is XPH's expense ratio?

State Street SPDR S&P Pharmaceuticals ETF charges an annual expense ratio of 0.35%. The fund is issued by State Street Global Advisors.

### How large is XPH?

State Street SPDR S&P Pharmaceuticals ETF manages $444.2M in assets and has traded since Jun 19, 2006.

### How do I buy shares of State Street SPDR S&P Pharmaceuticals ETF (XPH)?

XPH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).